The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Wockhardt Limited, a global pharmaceutical company headquartered in India, have partnered to produce and supply Sputnik V and Sputnik Light vaccines against COVID-19. The agreement was reached under the aegis of Enso Healthcare (part of Enso Group), RDIF’s coordination partner for sourcing Sputnik V…
Tag: Sputnik V
Dr. Reddy’s Announces Launch of the Sputnik V vaccine in the Indian Market
by
•Dr. Reddy’s Laboratories Ltd. announced that the first consignment of imported doses of the Sputnik V vaccine that landed in India on 1 st May, 2021, received regulatory clearance from the Central Drugs Laboratory, Kasauli, on 13th May, 2021. As part of a limited pilot, the soft launch of the vaccine has commenced and the…
RDIF and Stelis Biopharma partner to supply 200 million doses of the Sputnik V vaccine
by
•The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Stelis Biopharma Pvt. Ltd., the biopharmaceutical division of Strides, a global pharmaceutical company headquartered in India, have partnered to produce, and supply a minimum of 200 million doses of the Russian Sputnik V vaccine against coronavirus sufficient to vaccinate 100 million people. The agreement…
Dr. Reddy’s join hands with BIRAC for Sputnik V vaccine clinical trials in India
by
•Dr. Reddy’s Laboratories announced its partnership with Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT), Government of India, for advisory support on clinical trials of Sputnik V vaccine in India. The partnership will allow Dr. Reddy’s to identify and use some of BIRAC’s clinical trial centres for the vaccine, which are funded under…
Dr. Reddy’s to conduct phase 2/3 human clinical trial for Sputnik V vaccine in India
by
•Dr. Reddy’s Laboratories Ltd. and Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, announced that they have received approval from the Drug Control General of India (DCGI) to conduct an adaptive phase 2/3 human clinical trial for Sputnik V vaccine in India. This will be a multicenter and randomized controlled study, which will include…
RDIF and Dr Reddy’s partner to conduct clinical trials and supply 100 mn doses of Sputnik V vaccine to India
by
•The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Dr. Reddy’s Laboratories Ltd, a global pharmaceutical company headquartered out of India, announced that they have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India. Upon regulatory approval in India, RDIF shall supply to Dr. Reddy’s 100 million doses…